ZYVERSA THERAPEUTICS, INC. Proceeds from (Payments for) Other Financing Activities
ZYVERSA THERAPEUTICS, INC. (ZVSA) reported Proceeds from (Payments for) Other Financing Activities of $12.51 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-19.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2026-03-31
- ZYVERSA THERAPEUTICS, INC. proceeds from (payments for) other financing activities for the quarter ending 2024-12-31 was -$9.90K.
- ZYVERSA THERAPEUTICS, INC. proceeds from (payments for) other financing activities for fiscal 2024 was -$40.16K.
| Period end | Proceeds from (Payments for) Other Financing Activities 3 month | Proceeds from (Payments for) Other Financing Activities 9 month | Proceeds from (Payments for) Other Financing Activities 12 month |
|---|---|---|---|
| 2025-09-30 | $12.51K 10-Q · filed 2025-11-19 | ||
| 2024-12-31 | -$9.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$40.16K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$30.26K 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |